Korean Market
EXCH
HUONS
★

HUONS Changes Extraordinary General Meeting to August 21, 2026 to Approve Merger and Expand Business Objectives

 
MATR
HUONS
★

Huons decides to absorb subsidiary Huons Lab... 24.2% dilution despite expected R&D synergy

 
MATR
HUONS
★

Huons Decides to Merge with Subsidiary Huons Lab... 24.2% New Shares Dilution, Long-term R&D Synergy Expected

 
EXCH
HUONS
★

Huons Approves Small-Scale Merger of Subsidiary Huons Life Science Without Issuing New Shares; Opposition Only 0.5%

 
EXCH
HUONS
★

Lifting of Trading Halt on May 19, 2026 Due to Non-Applicability of Backdoor Listing

 
EXCH
HUONS
★

Call for Extraordinary General Meeting to Approve Merger and Amend Articles

 
EXCH
HUONS
★

Setting of Record Date for Exercise of Voting Rights at Extraordinary General Meeting

 
EXCH
HUONS
★★★

Trading Suspension Due to Backdoor Listing Review

 
MATR
HUONS
★

Huons Decides to Absorb Affiliate Huons Lab, Appraisal Right Price at 32,886 Won

 
PERI
HUONS
★★

Huons Q1 2026: Operating Loss but Net Profit Positive, New Dividend Policy and Merger Announced

 
EXCH
HUONS
★

Response to Inquiry on Affiliate Merger Rumors (Under Review, Not Finalized)

 
EXCH
HUONS
★★

Huons Decides Quarterly Cash Dividend of 200 Won Per Share

 
EXCH
HUONS
★

Record Date Set for 2026 Quarterly Dividend

 
EXCH
HUONS
★

Inquiry Disclosure Request on Affiliated Company Merger Rumors

 
EXCH
HUONS
★★★

Consolidated Provisional Results for Q1 2026: Operating Profit Turns to Loss, Net Profit Plunges 98.5%